Amalgamated Bank’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Amalgamated Bank's NUVB Position: Q1 2026 in Review
Amalgamated Bank sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 7,578 shares — an estimated $68K sold.
Amalgamated Bank first reported a position in NUVB in Q3 2021 and held it in 18 quarters. The position peaked at $228K in Q4 2021. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Amalgamated Bank reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 7,578 Nuvation Bio shares in Q1 2026, an estimated $68K.
- Amalgamated Bank first reported a position in Nuvation Bio in Q3 2021 and held it in 18 quarters.
- Amalgamated Bank's Nuvation Bio position peaked at $228K in Q4 2021.
- 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.